Dr. Jordan J. Williams

Dr. Jordan J. WilliamsMarquette University

Olin Engineering, 338A

MilwaukeeWI53201United States of America(414) 288-7569jordan.j.williams@marquette.eduGoogle Scholar

Curriculum Vitae

Assistant Professor

Joint Department of Biomedical Engineering

Director

The Neural Engineering, Interfacing, Modulation and Optimization Laboratory (NEIMO)

Professional Preparation

• Postdoctoral Scholar, 2013-2019, Systems Neuroscience Institute, University of Pittsburgh
• M.D., 2013, Washington University in St. Louis
• Ph.D., 2013, Biomedical Engineering, Washington University in St. Louis
• B.S., 2005, Electrical Engineering, South Dakota State University
• B.S., 2005, Engineering Physics, South Dakota State University

Courses Taught

BIEN 3310 Control Systems for Biomedical Engineering—An introduction to the principles of control systems theory for biomedical engineers

BIEN 6200 Biomedical Signal Processing—Introduction to statistical processing of biomedical data and applying it to physiologic signals

View ALL BIEN Courses

Research Interests

• Peripheral optogenetics for motor stimulation
• Brain-machine interfaces and neural prosthetics
• Viral gene therapy for spinal cord injury and disease
• Neural correlates of motor learning

Selected Recent Publications

Recent Grants

Williams, Jordan (Co-Investigator); Budde, Matthew (Principal Investigator); "Spreading Depolarizations and Perfusion in Non-traumatic Spinal Cord Injury." Sponsored by the Veterans Administration (October 2021–September 2023). 

Williams, Jordan; “Addressing the clinical feasibility of peripheral optogenetic strategies for spinal cord injury rehabilitation,” an NIH K12 grant sponsored by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health, award number K12HD073945 (January 1, 2022–December 31, 2022).  

Williams, Jordan (Principal Investigator); "Peripheral Optogenetic Restoration of Motor Function Following Spinal Cord Injury." Sponsored by the Morton Cure Paralysis Fund (July 2021–June 2022).